CROS NT Jumps into Medical Device Space with US Acquisition
European CRO CROS NT has acquired US medical device CRO Stat-Tech Services to try to take a slice of the growing medical device trial sector.
European CRO CROS NT has acquired US medical device CRO Stat-Tech Services to try to take a slice of the growing medical device trial sector.
Argentinian regulators are unsure how best to implement new gluten-free rules for drugs that could mean all excipients need to be tested.
Regulators in Southeast Asia say draft process validation guidelines issued for consultation last week are a work in progress and likely to change as discussions continue.
India’s top drug regulator on Wednesday unveiled a list of all the pending clinical trials before its apex committee, which includes information on what the top CROs are working on in the subcontinent.
Cargill says interest from the pharma industry for its seaweed-derived excipient is growing as it invests $15m (€11.3m) into its French alginate production plant.
In a first for CROs, INC Research has implemented an international accreditation program for its clinical research associates to further understand trial monitoring and ensure consistency for biopharma sponsors.